| # | Drug | Count |
|---|---|---|
| 0 | ORLISTAT | 2423 |
| 1 | ADALIMUMAB | 238 |
| 2 | VEDOLIZUMAB | 168 |
| 3 | PREDNISONE | 97 |
| 4 | INFLIXIMAB | 79 |
| 5 | AZATHIOPRINE | 65 |
| 6 | OMEPRAZOLE MAGNESIUM | 57 |
| 7 | LEVOTHYROXINE SODIUM | 55 |
| 8 | OMEPRAZOLE | 47 |
| 9 | METHOTREXATE | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORLISTAT | 2423 | 0.1031 |
| 1 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, AND DIMETHICONE | 1 | 0.0769 |
| 2 | SODIUM CHLORITE | 1 | 0.0588 |
| 3 | FERRIC SULFATE | 1 | 0.0125 |
| 4 | LACTULOSE SOLUTION USP, 10 G/15 ML | 1 | 0.0099 |
| 5 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, AND SODIUM CHLORIDE FOR ORAL SOLUTION | 1 | 0.0093 |
| 6 | PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE | 6 | 0.0074 |
| 7 | L-TYROSINE | 1 | 0.0074 |
| 8 | UNDECYLENIC ACID | 1 | 0.0072 |
| 9 | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | 1 | 0.0068 |
| # | Drug class | Count |
|---|---|---|
| 0 | Intestinal Lipase Inhibitor [EPC] | 2433 |
| 1 | Integrin Receptor Antagonist [EPC] | 173 |
| 2 | Corticosteroid [EPC] | 154 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 131 |
| 4 | Benzodiazepine [EPC] | 90 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 88 |
| 6 | Aminosalicylate [EPC] | 76 |
| 7 | Vitamin C [EPC] | 68 |
| 8 | Provitamin D2 Compound [EPC] | 66 |
| 9 | Purine Antimetabolite [EPC] | 65 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Intestinal Lipase Inhibitor [EPC] | 2433 | 0.1035 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 8 | 0.0039 |
| 2 | Provitamin D2 Compound [EPC] | 66 | 0.0022 |
| 3 | Integrin Receptor Antagonist [EPC] | 173 | 0.0020 |
| 4 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | GLP-2 Analog [EPC] | 17 | 0.0013 |
| 7 | mu-Opioid Receptor Agonist [EPC] | 3 | 0.0010 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 9 | Photoenhancer [EPC] | 3 | 0.0008 |